For the year ending 2025-12-31, PSTV made $5,213K in revenue. -$22,386K in net income. Net profit margin of -429.43%.
| Income Statement | 2025-12-31 | 2024-12-31 | ||
|---|---|---|---|---|
| Revenue | 5,213 | 5,824 | ||
| Research and development | 8,379 | 10,580 | ||
| General and administrative | 12,132 | 9,939 | ||
| Total operating expenses | 20,511 | 20,519 | ||
| Operating loss | -15,298 | -14,695 | ||
| Financing expense | 3,061 | 3,545 | ||
| Change in fair value of warrants | - | -5,654 | ||
| Change in fair value of derivative instruments | 2,631 | - | ||
| Warrant issuance costs | 964 | 486 | ||
| Interest income | 116 | 273 | ||
| Interest expense | 548 | 179 | ||
| Total other income (expense) | -7,088 | 1,717 | ||
| Net loss | -22,386 | -12,978 | ||
| Basic EPS | -0.29 | -1.95 | ||
| Diluted EPS | -0.29 | -2.34 | ||
| Basic Average Shares | 77,804,612 | 6,640,251 | ||
| Diluted Average Shares | 77,804,612 | 7,700,774 | ||
PLUS THERAPEUTICS, INC. (PSTV)
PLUS THERAPEUTICS, INC. (PSTV)